Cargando…

The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells

Enhancer of zeste homolog 2 (EZH2) is the catalytic unit of polycomb repressive complex 2 (PRC2) which epigenetically silences many genes involved in tumor-suppressive mechanisms via the trimethylation of lysine 27 of histone H3 (H3K27me3). We recently found that overexpression of EZH2 was associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Tianfu, Wang, Yingyi, Hu, Qi, Wu, WeiNing, Wu, Youzhi, Wei, Wenjin, Han, Dongfeng, You, Yongping, Lin, Ning, Liu, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716734/ https://www.ncbi.nlm.nih.gov/pubmed/29228694 http://dx.doi.org/10.18632/oncotarget.21311

Ejemplares similares

Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma
por: Wang, Yingyi, et al.
Publicado: (2016)

EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma
por: Zhi, Tongle, et al.
Publicado: (2017)

EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders
por: Yue, Dongyou, et al.
Publicado: (2021)

CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1
por: Yu, Tianfu, et al.
Publicado: (2017)

Polycomb group expression signatures in the malignant progression of gliomas
por: Hu, Qi, et al.
Publicado: (2017)

NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells
por: Han, Dongfeng, et al.
Publicado: (2015)

The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression
por: Wu, Weining, et al.
Publicado: (2019)

In silico and experimental analyses predict the therapeutic value of an EZH2 inhibitor GSK343 against hepatocellular carcinoma through the induction of metallothionein genes
por: Liu, Tsang-Pai, et al.
Publicado: (2016)

Hypoxia induces H19 expression through direct and indirect Hif-1α activity, promoting oncogenic effects in glioblastoma
por: Wu, Weining, et al.
Publicado: (2017)

MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53
por: Zhou, Xu, et al.
Publicado: (2017)

Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration
por: Mannino, Deborah, et al.
Publicado: (2023)

Treatment of calcific arterial disease via enhancement of autophagy using GSK343
por: Lino Cardenas, Christian L., et al.
Publicado: (2023)

Inhibition of histone methyltransferase EZH2 in Schistosoma mansoni in vitro by GSK343 reduces egg laying and decreases the expression of genes implicated in DNA replication and noncoding RNA metabolism
por: Pereira, Adriana S. A., et al.
Publicado: (2018)

Diverse Macrophages Constituted the Glioma Microenvironment and Influenced by PTEN Status
por: Zhou, Fengqi, et al.
Publicado: (2022)

GSK-3β regulates tumor growth and angiogenesis in human glioma cells
por: Zhao, Peng, et al.
Publicado: (2015)

Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
por: Nie, Er, et al.
Publicado: (2018)

PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop
por: Luan, Wenkang, et al.
Publicado: (2015)

MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells()
por: Li, Ping, et al.
Publicado: (2010)

GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells
por: Xu, Hao, et al.
Publicado: (2019)

Diosgenin and GSK126 Produce Synergistic Effects on Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway
por: Liu, Shanshan, et al.
Publicado: (2020)

BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53
por: Nie, Er, et al.
Publicado: (2016)

Wedelolactone Promotes the Chondrogenic Differentiation of Mesenchymal Stem Cells by Suppressing EZH2
por: Qin, Wei, et al.
Publicado: (2023)

An Axis Involving SNAI1, microRNA-128 and SP1 Modulates Glioma Progression
por: Dong, Qingsheng, et al.
Publicado: (2014)

Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma
por: Wang, Hongjun, et al.
Publicado: (2015)

RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis
por: Shen, Feng, et al.
Publicado: (2018)

Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675
por: Shi, Yan, et al.
Publicado: (2014)

Health Tract No. 343: Ventilation
Publicado: (1868)

Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
por: Zhang, Qi, et al.
Publicado: (2017)

Vitamin D Enhances Radiosensitivity of Colorectal Cancer by Reversing Epithelial-Mesenchymal Transition
por: Yu, Xinyue, et al.
Publicado: (2021)

Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer
por: Wang, YouZhi, et al.
Publicado: (2021)

Correction: Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer
por: Wang, YouZhi, et al.
Publicado: (2021)

Alterations in gene expression profiles correlated with cisplatin cytotoxicity in the glioma U343 cell line
por: Carminati, Patricia Oliveira, et al.
Publicado: (2010)

Triptolide reverses epithelial-mesenchymal transition in glioma cells via inducing autophagy
por: Lai, Minfang, et al.
Publicado: (2021)

Upregulation of miR-340 Inhibits Tumor Growth and Mesenchymal Transition via Targeting c-MET in Glioblastoma
por: Lin, Ning, et al.
Publicado: (2020)

Health Tract No. 343: Food Cure
Publicado: (1868)

Prevalence and Clinicopathologic Characteristics of the Molecular Subtypes in Malignant Glioma: A Multi-Institutional Analysis of 941 Cases
por: Lin, Ning, et al.
Publicado: (2014)

Emodin Reverses the Epithelial–Mesenchymal Transition of Human Endometrial Stromal Cells by Inhibiting ILK/GSK-3β Pathway
por: Zheng, Qiaomei, et al.
Publicado: (2020)

PCI-24781 down-regulates EZH2 expression and then promotes glioma apoptosis by suppressing the PIK3K/Akt/mTOR pathway
por: Zhang, Wei, et al.
Publicado: (2014)

EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells
por: Cardenas, Horacio, et al.
Publicado: (2016)

Sortilin promotes glioblastoma invasion and mesenchymal transition through GSK-3β/β-catenin/twist pathway
por: Yang, Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n69ibesqg2diithqm6pac4ab30